Compare, Analyse Panacea Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs MYLAN (US) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   MYLAN
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
MYLAN
Dec-18
PANACEA BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3543,495-   
Low Rs1381,924-   
Sales per share (Unadj.) Rs74.61,608.1-  
Earnings per share (Unadj.) Rs6.743.7-  
Cash flow per share (Unadj.) Rs15.5344.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.21,739.7-  
Shares outstanding (eoy) m61.25514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.7 195.8%   
Avg P/E ratio x36.862.0 59.3%  
P/CF ratio (eoy) x15.97.9 201.9%  
Price / Book Value ratio x4.31.6 276.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,0611,393,882 1.1%   
No. of employees `0002.335.0 6.6%   
Total wages/salary Rs m1,4710-   
Avg. sales/employee Rs Th1,973.623,639.1 8.3%   
Avg. wages/employee Rs Th635.60-   
Avg. net profit/employee Rs Th176.8641.9 27.5%   
INCOME DATA
Net Sales Rs m4,567827,370 0.6%  
Other income Rs m450-   
Total revenues Rs m4,612827,370 0.6%   
Gross profit Rs m2,030214,093 0.9%  
Depreciation Rs m540154,916 0.3%   
Interest Rs m1,04839,794 2.6%   
Profit before tax Rs m48619,383 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-3,084 -2.5%   
Profit after tax Rs m40922,467 1.8%  
Gross profit margin %44.425.9 171.8%  
Effective tax rate %15.9-15.9 -99.7%   
Net profit margin %9.02.7 329.9%  
BALANCE SHEET DATA
Current assets Rs m2,415462,003 0.5%   
Current liabilities Rs m9,077336,851 2.7%   
Net working cap to sales %-145.915.1 -964.5%  
Current ratio x0.31.4 19.4%  
Inventory Days Days6584 77.9%  
Debtors Days Days7193 76.0%  
Net fixed assets Rs m8,333160,496 5.2%   
Share capital Rs m61441 13.9%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,504895,063 0.4%   
Long term debt Rs m461966,060 0.0%   
Total assets Rs m13,7552,400,907 0.6%  
Interest coverage x1.51.5 98.4%   
Debt to equity ratio x0.11.1 12.2%  
Sales to assets ratio x0.30.3 96.3%   
Return on assets %10.62.6 408.6%  
Return on equity %11.72.5 465.1%  
Return on capital %38.73.2 1,217.1%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,049171,928 0.6%  
From Investments Rs m-54-88,868 0.1%  
From Financial Activity Rs m-1,011-80,094 1.3%  
Net Cashflow Rs m-201,424 -1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.42 Rs / USD

Compare PANACEA BIOTECH With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views On News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


Mar 2, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - SUVEN LIFE SCIENCES COMPARISON

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS